Skin Cancer Risk in Patients with Mutations
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Eide M, Krajenta R, Johnson D, Long J, Jacobsen G, Asgari M
. Identification of patients with nonmelanoma skin cancer using health maintenance organization claims data. Am J Epidemiol. 2009; 171(1):123-8.
PMC: 2796985.
DOI: 10.1093/aje/kwp352.
View
2.
Desmond A, Kurian A, Gabree M, Mills M, Anderson M, Kobayashi Y
. Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment. JAMA Oncol. 2015; 1(7):943-51.
DOI: 10.1001/jamaoncol.2015.2690.
View
3.
Levy-Lahad E, Friedman E
. Cancer risks among BRCA1 and BRCA2 mutation carriers. Br J Cancer. 2007; 96(1):11-5.
PMC: 2360226.
DOI: 10.1038/sj.bjc.6603535.
View
4.
Gumaste P, Penn L, Cymerman R, Kirchhoff T, Polsky D, McLellan B
. Skin cancer risk in BRCA1/2 mutation carriers. Br J Dermatol. 2014; 172(6):1498-1506.
PMC: 5785081.
DOI: 10.1111/bjd.13626.
View
5.
Welch H, Mazer B, Adamson A
. The Rapid Rise in Cutaneous Melanoma Diagnoses. N Engl J Med. 2021; 384(1):72-79.
DOI: 10.1056/NEJMsb2019760.
View